Why would a CRO assume the inherent risk in failed trials?
No, they'd want to be paid in cash and to leave the shareholders all the risk that the trial could be a washout.
It's the same reason your hardworking CEO and BOD want to be paid in cash. Being paid in shares in a highly risky Biotech company is a mug's game. They are way to smart for that.
Anyway they can award themselves with some nice bonus shares if the trial is sucessful, you know for all their hardwork for you.
Why would a CRO assume the inherent risk in failed trials?No,...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
